Recombinant TNFRSF10B (Drozitumab Biosimilar) antibody

Catalog No. ABIN7675895

This Human Monoclonal antibody specifically detects TNFRSF10B (Drozitumab Biosimilar) in FACS, BLI, ELISA, Func and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant TNFRSF10B (Drozitumab Biosimilar) antibody (ABIN7675895)

Target: TNFRSF10B (Drozitumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFRSF10B (Drozitumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), ELISA, Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-TNFRSF10B (Drozitumab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab)

Characteristics: Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TNFRSF10B (Drozitumab Biosimilar)

Target: TNFRSF10B (Drozitumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: O14763